Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Notice to attend the annual general meeting in SciBase Holding AB (publ)

Published

on

notice-to-attend-the-annual-general-meeting-in-scibase-holding-ab-(publ)

STOCKHOLM, May 13, 2024 /PRNewswire/ — The shareholders in SciBase Holding AB (publ), reg. no. 556773-4768 (the “Company”), are hereby given notice to attend the annual general meeting at 15:00 p.m. on Thursday 13 June 2024 at Setterwalls Advokatbyrå’s offices at address Sturegatan 10 in Stockholm. Registration for the meeting commences at 14:45 p.m. The board of directors has decided, pursuant to Chapter 7, Section 4a of the Swedish Companies Act and the Company’s articles of association, to apply the possibility of postal voting in conjunction with the general meeting (see “Postal voting” below for more information).

Notice
Shareholders wishing to participate at the meeting must:
be entered in the shareholders’ register, kept by Euroclear Sweden AB (the Swedish Central Securities Depository & Clearing Organisation), on the record day, which is Tuesday 4 June 2024, andnotify the Company of their attendance and any assistant no later than Friday 7 June 2024. Notification can be made in writing to Setterwalls Advokatbyrå AB, Attn: Eric Torstensson, P.O. Box 1050, SE-101 39 Stockholm, Sweden or by e-mail to [email protected] shall include full name, personal identification number or corporate registration number, address, daytime telephone number and, if appropriate, information about representative, proxy, and assistants. The number of assistants may not be more than two. In order to facilitate entry to the meeting, notification should, where appropriate, be ac-companied by powers of attorney, registration certificates and other documents of authority.
Nominee registered shares
In order to be entitled to participate and vote at the meeting, shareholders who have their shares registered in the name of a nominee must have their shares registered in their own name, so that the shareholder will be included in the transcription of the share register as of Tuesday 4 June 2024. Such registration may be temporary (so-called voting rights registration) and is requested to the nominee in accordance with the nominee’s routines at such time in advance as the nominee determines. Voting rights registrations made by the nominee no later than Friday 7 June 2024 will be taken into account in the preparation of the share register.
Postal voting
The board of directors has decided, pursuant to Chapter 7, Section 4a of the Swedish Companies Act and the Company’s articles of association, to apply the possibility of postal voting in conjunction with the general meeting. A special form shall be used for postal voting. The form will be available on the Company’s website, https://investors.scibase.se/en/governance/annual-general-meeting.
The form may be submitted by post to Setterwalls Advokatbyrå AB, Attn: Eric Torstensson, P.O. Box 1050, 101 39 Stockholm or via e-mail to [email protected]. The completed voting form must be received by Setterwalls Advokatbyrå AB no later than Wednesday 12 June 2024 provided the shareholder has given notice of attendance at the general meeting no later than Friday 7 June 2024. However, a complete postal vote which reaches Setterwalls Advokatbyrå AB no later than Friday 7 June 2024 shall also be considered the shareholder’s notice of attendance at the meeting (by postal voting).
The shareholder may not provide special instructions or conditions in the voting form. If so, the vote (i.e. the postal vote in its entirety) is invalid. Further instructions and conditions are included in the form for postal voting.
Proxy voting
A shareholder represented by proxy shall issue a power of attorney which shall be dated and signed by the shareholder. If the shareholder postal votes by proxy, the power of attorney shall be enclosed to the form. If issued by a legal entity, the power of attorney shall also be accompanied by registration certificate or, if not applicable, equivalent documents of authority. Power of attorney forms will be available on the Company’s website https://investors.scibase.se/en/annual-general-meeting-2024.
Processing of personal data
For information regarding how your personal data is processed in connection with the annual general meeting, please refer to the privacy policy on Euroclear Sweden AB’s website, https://www.euroclear.com/dam/ESw/Legal/Privacy-notice-bolagsstammor-engelska.pdf.
Proposed agenda
Opening of the meeting and election of chairman of the meeting.Preparation and approval of the voting list.Approval of the agenda.Election of one person who shall approve the minutes of the meeting.Determination of whether the meeting has been duly convened.Submission of the annual report and the auditor’s report as well as of the consolidated financial statements and the auditor’s report on the group.Resolution in respect of:adoption of the profit and loss statement and the balance sheet as well as of the consolidated profit and loss statement and the consolidated balance sheet;  allocation of the Company’s results according to the adopted balance sheet; andthe members of the board of directors’ and the CEO’s discharge from liability.Resolution regarding the number of members and, where applicable, deputies of the board of directors and number of auditors and, where applicable, deputy auditors.Determination of the fees payable to the members of the board of directors and the auditors.Election of members of the board of directors and auditor.Resolution on principles for the appointment of a nomination committee.Resolution on an authorisation for the board of directors to resolve upon issues of shares, warrants and convertibles.Closing of the meeting.The nomination committee’s proposed resolutions
The nomination committee is composed of the chairman of the board of directors of the Company (i.e. Tord Lendau), Thomas Axelsson (appointed by Gell Group), Dharminder Chahal (appointed by VanHerk Group), and Peter Elmvik (appointed by Stockholms Elbolag). The nomination committee has presented the following proposed resolutions in relation to items 1 and 8-11 in the proposed agenda.  
Item 1 – Election of chairman
Axel Helle (lawyer at Setterwalls Advokatbyrå AB) is proposed as chairman of the meeting, or if he is unable to attend the meeting, any other person proposed by the board of directors.
Items 8-10 – Resolution regarding the number and election of and remuneration to the board of directors and auditors
The nomination committee proposes that the board of directors, until the end of the next annual general meeting, shall consist of four (4) ordinary members without deputy members. Furthermore, it is proposed that a registered accounting firm shall be elected as auditor.
The nomination committee furthermore proposes that the fees payable to the board of directors for the period until the end of the next annual general meeting shall be SEK 200,000 for the chairman of the board and SEK 150,000 to each of the other ordinary board members (who are not employed by a larger shareholder in the Company). It is proposed that the Company’s auditor shall be paid in accordance with approved invoices.
The board of directors today consists of the following five (5) ordinary members without deputy members: Tord Lendau (chairman), Diana Ferro, Thomas Taapken, Matt Leavitt och Jvalini Dwarkasing.
Tord Lendau has declined re-election after ten years as chairman of the board of directors. Matt Leavitt and Jvalini Dwarkasing have also declined re-election. However, Matt Leavitt will continue to assist the Company on a consultancy basis.
The nomination committee proposes that Diana Ferro and Thomas Taapken are re-elected and that Jesper Høiland and Robert Molander are new-elected as ordinary board members. Furthermore, Jesper Høiland is proposed to be new-elected as chairman of the board of directors.
The registered accounting firm PricewaterhouseCoopers AB (PwC) is proposed to be re-elected as auditor. The accounting firm has informed that Magnus Lagerberg will remain as principally responsible auditor.
The nomination committee has, as the basis for its proposal, regarding the composition of the board of directors, discussed the Company’s future needs and reviewed the annual evaluation of the board of directors and its work and interviewed several candidates. The nomination committee has thoroughly discussed the requirements for competence, experience and background that are placed on the board of directors of Scibase, considering, among other things, the Company’s strategic development, governance and control. Independence issues have been highlighted, as well as the requirement for versatility and breadth in the board. The nomination committee makes the assessment that the proposed board members, considering the Company’s needs, operations, stage of development and other circumstances, would give the board of directors a good and appropriate composition.
Below is a summarized description of the proposed new board members’ education, experience, other assignments, and independence. Further information about all proposed board members will be made available on the Company’s website.
Jesper Høiland
Education: MSc and BSc, Copenhagen Business School.
Experience: Jesper has over 25 years of experience from senior positions in global pharmaceutical companies such as Ascendis Pharma (CCO), Radius Health (CEO) and Novo Nordisk (President and EVP for the US with a particular focus on pricing, product launches and infrastructure building). Jesper has previously been a board member of Concert Pharma and Leo Pharma. Jesper has lived and worked in the US, Switzerland, Denmark, Australia, France, Belgium and Canada for the past 30 years.
Other current assignments: Strategic advisor to pharmaceutical and medical device companies. Member of the board of directors and the audit committee of ALK.
Independence: Jesper is independent in relation to the Company and its management as well as to major shareholders.
Robert Molander
Education: MBA in Marketing and Finance, Washington University, John M. Olin School of Business and dual BA degrees in Economics and International Studies, Miami University.
Experience: Senior executive and advisor with over 25 years of expertise in life science commercialization, primarily based in the United States. Robert has successfully led companies such as Novartis, Pfizer, Shionogi, and Trialbee through product launches, business development and scaling commercial operations. Robert has previously been Chief Commercial Officer at Infant Bacterial Therapeutics AB and Trialbee AB and a board member of Infant Bacterial Therapeutics AB.
Other current assignments: Board member of Xspray Pharma AB, CEO of Stratfox Healthcare Group LLC.
Independence: Robert is independent in relation to the Company and its management and to major shareholders.
Item 11 – Resolution on principles for the appointment of a nomination committee
The nomination committee proposes the following decision for appointment of a nomination committee for the annual general meeting 2025 (same principles as the previous year). The nomination committee for the annual general meeting 2025, which shall be comprised of four members, shall be appointed by way of that the chairman of the board of directors will consult with the three largest shareholders of the Company at the end of the third quarter of 2024. These shareholders will be requested to each appoint one member who, together with the chairman of the board of directors, will form the nomination committee. The composition of the nomination committee shall be publicly announced no later than six months prior to the annual general meeting. The nomination committee, whose mandate period applies until the time a new nomination committee has constituted itself, shall appoint a chairman among its members. The nomination committee shall prior to the annual general meeting 2025 prepare and submit proposals regarding the election of the chairman of the annual general meeting, the number of board members and, where applicable, deputy members, the number of auditors and, where applicable, deputy auditors, the election of board members, chairman and, where applicable, deputy members, auditor and, where applicable, deputy auditors, remuneration for the board of directors and the auditor, as well as guidelines for the appointment of the nomination committee for the following annual general meeting. The nomination committee’s proposals shall be presented in the notice to a general meeting where election of board members and auditor shall take place and on the Company’s website. Should a member of the nomination committee resign from its assignment, a replacement shall be sought from the shareholder that appointed the departing member. Should a shareholder that has appointed a member of the nomination committee substantially decrease its ownership in the Company, the next shareholder in size order shall, if the nomination committee so resolves, be requested to appoint a member to the nomination committee.
The board of directors’ proposed resolutions
The board of directors of the Company has presented the following proposed resolutions in relation to items 7(ii), and 12 in the proposed agenda. 
Item 7 (ii) – Allocation of the Company’s results according to the adopted balance sheet 
The board of directors proposes that SEK 202,523,429 shall be carried forward in new account. Accordingly, no dividend is proposed.
Item 12 – Resolution regarding authorisation for the board of directors to resolve upon issues of shares, warrants and convertibles
The board of directors proposes that the annual general meeting resolves to authorize the board of directors to, until the next annual general meeting, on one or more occasions, decide upon issuances of new shares, issuance of warrants and/or convertibles. New issues of shares and issues of warrants and/or convertibles may occur with or without preferential rights for shareholders of the Company and may be made either in cash and/or by way of set-off or contribution in kind or otherwise be conditional. Through issuances resolved upon with support from the authorisation – with deviation from the shareholders’ preferential rights – the number of shares issued, or number of shares created in connection with exercise of warrants or conversion of convertibles, shall correspond to not more than a 20 per cent dilution of the share capital and the number of shares and votes in the Company after such issue(s). The chairman of the board of directors, the CEO or a person appointed by the board of directors shall be authorized to make any minor adjustments required to register the resolution with the Swedish Companies Registration Office. 
Majority requirements
Resolution in accordance with the board of director’s proposal in accordance with item 12 on the agenda requires that the general meeting’s resolution is supported by shareholders representing at least two thirds of the shares represented at the general meeting as well as of the votes cast.
Shareholders’ right to request information
The board of directors and the CEO shall, if any shareholder so requests and the board of directors believe that it can be done without material damage to the Company, provide information regarding circumstances that may affect the assessment of an item on the agenda, of the Company’s, or a subsidiary’s economic situation and of the Company’s relations with other group companies on the general meeting.
Documentation
The financial accounts and auditor’s report will be kept available at the Company’s office and on the Company’s website www.scibase.com. Copies of such documents will be sent free of charge to shareholders who so request and state their postal address. The proposals of the board of directors and the nomination committee are set out in full in the notice.
Stockholm, May 2024SciBase Holding AB (publ)The board of directors
For more information, please contact:Pia Renaudin, CEO SciBaseTel: +46 73 206 98 02Email: [email protected]
Certified Adviser: Vator SecuritiesTel: +46 8 580 065 99Email: [email protected]
The information was submitted, through the agency of the contact person set out above, for publication at the time stated by Scibase’s news distributor Cision upon publication of this press release
About SciBase
SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops and commercializes Nevisense, a unique point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management.
Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs.
Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in dermatological advancements.
The company has been on the Nasdaq First North Growth Market exchange since June 2, 2015. Learn more at www.scibase.com. All press releases and financial reports can be found here: https://investors.scibase.se/en/pressreleases.
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/scibase/r/notice-to-attend-the-annual-general-meeting-in-scibase-holding-ab–publ-,c3977598
The following files are available for download:
https://mb.cision.com/Main/12371/3977598/2790717.pdf
SciBase Holding AB (publ) – Notice to attend AGM 2024 (ENG)
 

View original content:https://www.prnewswire.co.uk/news-releases/notice-to-attend-the-annual-general-meeting-in-scibase-holding-ab-publ-302143390.html

Continue Reading
Advertisement
Stake.com

Artificial Intelligence

Trip.com Group Outlines Future Growth Strategies at Envision 2024 Global Partner Conference

Published

on

trip.com-group-outlines-future-growth-strategies-at-envision-2024-global-partner-conference

SHANGHAI, May 30, 2024 /PRNewswire/ — Trip.com Group set the stage for transformative growth at the Envision 2024 Global Partner Conference, sharing its strategic vision with over 1,600 partners from more than 50 countries and regions. The conference, focused on the forward-looking theme of “Charting the Next Chapter of Our Growth Together”, revealed pivotal trends and opportunities that will drive the travel industry forward.

The Spirit of Innovation in Travel
As the travel industry moves beyond the recovery phase and enters a period of rapid growth, a pressing question arises: “What comes next?” This anticipation was met with enthusiasm at the conference, where future growth areas were a focal point. The sustained investment in innovation and technological advancements emerged as a pivotal strategy, with a particular emphasis on the transformative potential of AI.
Mr. James Liang, Co-founder and Chairman of Trip.com Group, highlighted the key role of innovation in staying at the forefront of the travel industry, citing TripGenie, Trip.com’s AI travel assistant, as one of the innovative ways technology can revolutionise the travel planning and booking process.
“Every industry needs to innovate and so does the travel industry. We are constantly innovating in terms of efficiency, quality, customer service and even marketing. For instance, AI such as TripGenie can enhance customer service and marketing by integrating technology and content, to provide the best value to our customers,” he said.
Mr Liang also emphasised AI’s widespread impact on the travel industry, boosting productivity, enhancing customer service, and providing users with highly personalised travel recommendations.
For example, Trip.com’s AI-curated lists are able to provide travellers with the top-ranked offerings as well as the best deals. This enables a higher level of personalisation at every stage of the travel journey, with AI as a powerful enabler.
Expanding Fast on the World Stage
Ms. Jane Sun, CEO of Trip.com Group, highlighted that Trip.com Group has seen unprecedented growth in 2023. The Group’s international growth last year has been especially remarkable, with 100% international growth year-on-year. The first quarter of 2024 was also off to a strong start, with global travel provider Trip.com generating revenue with over 80% growth year-on-year.
Plans were shared for significant investments in the Asia-Pacific region, and further expansion into the rest of the world, positioning the company to capitalise on global opportunities. Additionally, the Group has forged strategic partnerships with tourism bureaus, major hotel chains, airlines, train operators, and local travel providers worldwide.
Currently, the company has over 1.7 million global accommodation listings, flights from over 600 airlines, and a network of over 90,000 ecosystem partners, including group tours, attractions, and car rental providers.
At the conference, China’s burgeoning potential in the global travel arena was also highlighted, with the further relaxation of visa-free restrictions, payment facilitations, and tourism promotion strategies such as free layover transit tours launched in Shanghai and engaging marketing campaigns that showcase the country’s offerings.
The Group also reiterated its commitment to quality customer service, revealing that the human touch is key to ensuring travellers enjoy a wonderful trip.
Sustainability was also another key theme, with Trip.com Group integrating strong ESG (Environmental, Social, and Governance) commitments into its business goals. These ESG initiatives include promoting low-carbon travel options, supporting family-friendly policies, and community revitalisation, all to ensure mutual benefits for customers, partners, and the wider community.
Sector Highlights
Key leaders from the Group also spoke on the breakthroughs and new developments in each sector, showcasing the multi-faceted world of travel. Highlights include:
Air Travel: Achieved record domestic travel and strong outbound growth, securing the top OTA position in the Asia-Pacific region.
Hotel Bookings: Significant growth with over 8,000 hotels offering Hotel+X products. Preferred Partner Program attracted 2,000+ partners, while Trip.Best expanded to over 20,000 hotels, with new themes: “boutique homestays” and “newly opened hotels”.
International Train Business: Expanded operations in Europe, and international ticket sales doubled in the latter half of 2023. Shown 122% year-on-year growth in early 2024.
Vacation Business: Record sales in vacation packages, and will expand ticketing services globally in the year ahead with 16 new sites and 8 new service languages. Plans to expand car rental services to Thailand, Japan and other markets.
Corporate Travel: Trip.Biz showed three-digit growth, with significant increases in hotel and flight bookings. Plans for expansion in Greater China, North Asia, Southeast Asia, Middle East, and site deployment in Europe, North America, and Oceania.
FinTech and TripLink: Expanded global presence by supporting 35 payment currencies, all international card schemes, and 25 local alternative payment methods. Expanded global insurance coverage for flights, hotels and rental cars.TripLink offers premium payment solutions to tourism partners.
Marketing Innovations: Successful mega-sales events, TV advertising and airport activations. Increased new user registrations and attained high conversion rates. Made strong destination marketing efforts with tourism boards worldwide.
Technological Advancements: Investments in technology centres. AI travel assistant TripGenie now supports voice and text conversations in nine languages, with new support for Italian, Dutch and Malay available by end June.
Customer Service: Trustpilot rating improved to 4.2 stars. Continuously enhancing AI capabilities in diverse markets and production lines to enhance service efficiency.
With diverse new developments launched by the company, Ms Sun took the opportunity to thank the Group’s partners for their support.
“The travel industry is a vital driver of global GDP and job creation, and at Trip.com Group, we are proud to be at the forefront, using travel as a bridge for peace and prosperity. With the support of our partners, we are ready to turn the page to the next chapter of our journey and embrace fresh opportunities together.”
About Trip.com Group
Trip.com Group is a leading global travel service provider comprising of Trip.com, Ctrip, Skyscanner, and Qunar. Across its platforms, Trip.com Group helps travellers around the world make informed and cost-effective bookings for travel products and services and enables partners to connect their offerings with users through the aggregation of comprehensive travel-related content and resources, and an advanced transaction platform consisting of apps, websites and 24/7 customer service centres. Founded in 1999 and listed on NASDAQ in 2003 and HKEX in 2021, Trip.com Group has become one of the best-known travel groups in the world, with the mission “to pursue the perfect trip for a better world”. Find out more about Trip.com Group here: group.trip.com.
Follow us on: X, Facebook, LinkedIn, and YouTube.
Photo – https://mma.prnewswire.com/media/2425663/image_1.jpgPhoto – https://mma.prnewswire.com/media/2425664/image_2.jpgPhoto – https://mma.prnewswire.com/media/2425665/3.jpgLogo – https://mma.prnewswire.com/media/1026638/Trip_com_Group_Logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/tripcom-group-outlines-future-growth-strategies-at-envision-2024-global-partner-conference-302159248.html

Continue Reading

Artificial Intelligence

iFOREX Launches Revolutionary AI Trading Assistant

Published

on

iforex-launches-revolutionary-ai-trading-assistant

ROAD TOWN, British Virgin Islands, May 30, 2024 /PRNewswire/ — iFOREX, a leading name in the world of online trading, is proud to announce the launch of its innovative artificial intelligence tool designed to enhance the trading experience for its users. This cutting-edge AI assistant is now live on the iFOREX website, providing traders with instant answers to their questions about trading with this renowned broker. 

Revolutionizing the Trading Experience
In a bid to stay ahead in the rapidly evolving trading industry, iFOREX has developed an AI tool that offers users the ability to ask a wide range of trading-related questions and receive immediate, accurate responses. Whether you’re a seasoned trader or a newcomer to the trading world, this AI assistant is set to become an invaluable resource for all your trading inquiries.
Empowering Traders with Information
The new AI assistant on the iFOREX platform is designed to address the needs of both novice and tech-savvy traders, who demand quick and reliable information. From understanding market concepts to navigating the iFOREX trading platform, users can now rely on this intelligent tool for comprehensive support.
“Trading can be complex and time-sensitive,” said a spokesperson from iFOREX. “Our new AI assistant is here to simplify the process, providing our clients with the information they need, precisely when they need it. This innovation underscores our commitment to leveraging the latest technology to enhance our clients’ trading experience.”
Explore the Future of Trading Today
Traders interested in experiencing this revolutionary AI assistant can visit the iFOREX website and start asking their trading questions immediately. This new tool represents a significant step forward in how iFOREX supports its users, offering them unprecedented access to information and assistance in real-time.
About iFOREX
iFOREX is a globally recognized broker, offering a wide range of trading instruments and services. With a commitment to innovation and customer satisfaction, iFOREX continues to lead the way in providing traders with the tools and resources they need to succeed.
For more information about the AI trading assistant or to start using it today, visit the [iFOREX website] at iforex.com.

View original content:https://www.prnewswire.co.uk/news-releases/iforex-launches-revolutionary-ai-trading-assistant-302159243.html

Continue Reading

Artificial Intelligence

SCOPE AI ENGAGES WITH AD AGENCIES AND NETWORKS TO OPTIMIZE GEM PLATFORM

Published

on

scope-ai-engages-with-ad-agencies-and-networks-to-optimize-gem-platform

VANCOUVER, BC, May 30, 2024 /PRNewswire/ — Scope AI Corp. (CSE: SCPE) (OTCQB: SCPCF) (FSE: VN8) (“Scope” or the “Company”) is excited to announce its collaboration with several leading ad agencies and ad networks. This initiative aims to gain insights into the primary challenges these organizations face in analyzing the efficacy of different ad creatives and page layouts, as well as the difficulties and costs associated with testing.

These friendly collaborations are part of Scope AI’s commitment to ensuring that the functionality and features of its GEM (General Enterprise Machine Learning) platform are the best market-product fit. By engaging directly with industry professionals, Scope AI is gathering critical feedback to refine and enhance GEM’s capabilities, making it a more valuable tool for advertisers, brands, agencies, and Adtech service providers.
GEM, Scope AI’s flagship product, is designed to revolutionize the advertising technology sector through advanced AI-driven visual recognition and neural network technology. The platform will enable users to streamline processes, maximize return on ad spend, and analyze user behavior through custom neural networks without the need for expensive and risky live campaign testing.
“Our approach is to start with the pain points of our potential users and build solutions based on those insights,” said James Young, CEO of Scope AI Corp. “We believe in understanding the real-world challenges faced by our partners, rather than falling into the common software trap of ‘build it and they will come.’ This collaboration ensures that GEM is not just another tool, but a solution that addresses the specific needs of the advertising community.”
Scope AI’s commitment to innovation and user-centric development is further evidenced by its expanding development team, which is focused on incorporating feedback from these collaborations into the GEM platform. By doing so, Scope AI aims to deliver cutting-edge AI solutions that drive growth, productivity, and campaign performance in the advertising technology sector.
About Scope AI Corp.:
Scope AI Corp. is a leading technology company headquartered in Vancouver, British Columbia, dedicated to advancing the field of artificial intelligence. With a focus on visual recognition and neural network technology, Scope is committed to empowering businesses and industries with innovative solutions that drive growth and innovation.
For more information please visit Scope AI Corp., [email protected], or follow along on social media.
LinkedIn: scope-ai-corpFacebook: Scope AI CorpTwitter: https://twitter.com/ScopeAICorp
Contact Information James Young, Chief Executive Officer(604) [email protected]
Cautionary Note Regarding Forward-Looking Statements
This news release contains forward-looking statements that constitute forward-looking information (collectively, “forward-looking statements”) within the meaning of applicable Canadian securities legislation. All statements in this news release that are not purely historical statements of fact are forward-looking statements and include statements regarding beliefs, plans, expectations, future, strategy, objectives, goals and targets, and more specifically, the use of proceeds of the Offering. Although the Company believes that such statements are reasonable and reflect expectations of future developments and other factors which management believes to be reasonable and relevant, the Company can give no assurance that such expectations will prove to be correct. Forward-looking statements are typically identified by words such as: “believes”, “expects”, “aim”, “anticipates”, “intends”, “estimates”, “plans”, “may”, “should”, “would”, “will”, “potential”, “scheduled” or variations of such words and phrases and similar expressions, which, by their nature, refer to future events or results that may, could, would, might or will occur or be taken or achieved. Forward-looking statements involve known and unknown risks and are based on assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, including, but not limited to, those risks and assumptions described in the Company’s prospectus dated August 10, 2022, a copy of which is available under the Company’s profile on SEDAR at www.sedar.com. While Scope considers these assumptions to be reasonable, based on information currently available, they may prove to be incorrect. Readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this press release. In addition, forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions, continued satisfaction of Canadian Securities Exchange requirements, product safety and recalls, regulatory compliance and risks associated with the Company’s business. For more information on the risks, uncertainties and assumptions that could cause anticipated opportunities and actual results to differ materially, please refer to the risk factors set out in the Company’s prospectus dated August 10, 2022, a copy of which is available under the Company’s profile on SEDAR at www.sedar.com. Forward-looking statements are made as of the date of this news release and, unless required by applicable law, the Company assumes no obligation to update the forward looking statements or to update the reasons why actual results could differ from those projected in these forward-looking statements. All forward-looking statements are qualified in their entirety by this cautionary statement.
The Canadian Securities Exchange has in no way passed upon the merits of the business of the Company and has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.
Logo – https://mma.prnewswire.com/media/2414853/4733184/Scope_AI_Corp_logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/scope-ai-engages-with-ad-agencies-and-networks-to-optimize-gem-platform-302158644.html

Continue Reading

Trending